About us

Company profile

We are a CDMO focused on filling, finishing, and lyophilizing injectable (bio) pharmaceutical products. We operate from our EMA and US-FDA-approved production site in Oss, the Netherlands. We can support the entire drug life cycle; from producing materials for toxicology studies to clinical material manufacturing (Phase I-III) as well as efficient preparation for PPQ campaigns and final market production using two automated filling lines. We also provide specialized small-scale (hand fill) services for personalized medicines, ensuring precision and flexibility.

We have the means, the motivation & expertise and infrastructure to bring your invention from the lab bench to the clinic and to the market. We are an experienced and reliable partner and we believe that every client is unique and important and therefore deserves personalized attention through tailor-made solutions. What sets us apart is our commitment to collaboration and flexibility throughout the process, all within the framework of the EMA and US-FDA rules and regulations.

In addition, we offer a broad range of support services such as process and formulation development, lyo-cycle development and/ or optimization, analytical development & validation, technical transfer, scale-up, process validation, stability studies, label & pack (including serialization), and final batch certification for release to clinic or market.

Ultimately, BioConnection drives healthcare innovation through strategic collaborations and emerging trend partnerships. While we do not engage in pharmacovigilance, our drug products are manufactured to meet strict quality standards that support this crucial aspect of the drug life cycle. We are committed to global health initiatives and sustainable manufacturing practices, improving access to life-saving medicines worldwide. Therefore, we would be delighted to discuss how we can support your projects.

Our mission

Being your partner of choice in the (Bio)Pharmaceutical industry

BioConnection fulfills the needs of innovative and generic (bio)pharmaceutical companies by offering flexible state-of-the-art development and GMP-compliant manufacturing services for sterile Drug Products, both commercial and clinical.

Being your partner
of choice in the
(Bio)Pharmaceutical industry

How we work

We have the means and expertise to bring your invention from the lab bench to the clinic and to the market. Utulizing our European network of development and manufacturing partners, we are able to provide tailor-made solutions and unchallenged flexibility.

At BioConnection, we believe that every client is unique, and every project deserves personalized attention and a tailor-made solution. We have a team of experienced and dedicated people across the (bio)pharmaceutical life cycle to ensure this.

A dedicated point of contact from our Program Management team will coordinate your project, together our specialists from the Quality and Production departments, we will enable you to get the best possible results.

What sets us apart is our commitment to collaboration and flexibility throughout the process all within the framework of the EMA and US-FDA rules and regulations.

Meet our team

Alexander WillemsePhD, MSc
Chief Executive Officer

Alexander Willemse

Alexander Willemse is the CEO of BioConnection BV since 2008.

Before joining BioConnection, Alexander built an extensive career within the pharmaceutical industry. He started at Organon NV in 1998 and joined OctoPlus in 2003, where he served as Managing Director of the CMO business. Alexander studied Chemical Engineering at Delft University of Technology, where he also earned his PhD. Throughout his career, he has shared his expertise as a lecturer at several universities, including courses such as Particle Size Measurement for Aerosol Systems at the University of California (UCLA) and Measuring Techniques for Biophysical Systems at the University of Leuven in Belgium. For many years, he contributed as a CMC expert to the course Drug Development Simulation, first through the Dutch Top Institute Pharma and later via Learning by Simulation. Alexander is (co-)author of more than 20 scientific publications and currently serves as a board member of HollandBIO, the association of biotech companies in the Netherlands. In recent years, he has also delivered an annual guest lecture at Delft University of Technology on the history and impact of injectable pharmaceutical development. Outside of work, Alexander enjoys spending time with his family. When time allows, he can often be found mountain biking, and during winter he enjoys skiing on slopes around the world.

“It is rewarding to see how our work contributes to the success of our customers and, ultimately, to the availability of new therapies. Over the past few years, the company has grown significantly, and we are committed to continuing this growth. I find the work both diverse and challenging, but above all it is our people who make the difference. We are a strong, dedicated team with a great spirit, always willing to go the extra mile for our projects and customers. Combined with a healthy sense of humor and a practical, down-to-earth approach, this truly makes for a winning team.”

Martijn Poels
Chief Financial Officer

Martijn Poels

Martijn Poels, joined us August 2023 as our Chief Financial Officer (CFO).

Martijn has a proven track record of success in optimizing financial performance and implementing effective financial controls. With over 25 years of experience in finance and accounting and a good understanding of financial markets and regulatory compliance, he brings a wealth of expertise to the company’s financial operations and ensures they are in line with industry standards.
As CFO, Martijn is responsible for overseeing all financial aspects of the company, including financial planning, budgeting, forecasting, and financial reporting. He works closely with the management team to develop and execute strategic financial initiatives to navigate BioConnection successfully into the next growth stages.

Prior to joining BioConnection, Martijn held senior finance positions at various companies, where he played a key role in driving financial success and implementing financial strategies that supported business objectives. The most significant part of this was in pharmaceutical companies such as Organon/Schering-Plough/MSD and DSM-Sinochem-Pharmaceuticals/Centrient.
Martijn holds a Master’s degree in Industrial Engineering & Management Science from Eindhoven University of Technology and an Executive Master of Finance & Control from Vrije Universiteit Amsterdam. He is a member of VRC (Association of registered controllers) and continues to stay updated with the latest trends and developments in the finance industry.

“It was at Organon in 2005 when I first learned about BioConnection, right after its inception. It is exciting to see how BioConnection has developed over all those years, particularly with the acquisition of its own manufacturing plant in 2016. It is great to be back in Oss and work with the team at BioConnection on the next steps in the growth journey of this company.”

Eva Stöcker
Director Production

Eva Stöcker

Eva Stöcker joined our company in December 2022 and is our Director Production

She brings extensive experience in operational management and leadership to the company. As Director Production, Eva oversees the day-to-day operations, ensuring smooth workflows and high-quality production standards. She is responsible for managing teams, optimizing resources, and implementing strategies that enhance operational performance. Eva’s expertise in team building and communication fosters a collaborative environment, enabling BioConnection to meet its production goals effectively.
With a background spanning over a decade in various operational roles, Eva is instrumental in driving efficiency and excellence within BioConnection’s production processes.

Prior to joining BioConnection, Eva held significant positions at MSD Animal Health Nederland and Applied Materials, where she honed her skills in operations management and project coordination. Her diverse experience includes roles such as Non-Technical Project/Program Manager and AGS Administrator, showcasing her ability to manage complex projects and operations.
Eva holds a Master of Science in Public Administration from Radboud Universiteit Nijmegen and a Bachelor’s degree in Facility Management from Hogeschool Diedenoort Wageningen. Her educational background, combined with her practical experience, equips her with the knowledge and skills necessary to lead operational initiatives at BioConnection.

“Joining BioConnection has been an exciting chapter in my career. The company’s commitment to innovation and quality aligns perfectly with my professional values. I am enthusiastic about contributing to BioConnection’s growth and success, particularly in enhancing our operational capabilities to meet the evolving needs of our customers.”

Richard SewaltPhD
Chief Commercial Officer

Richard Sewalt

Richard serves as Chief Commercial Officer at BioConnection in the Netherlands since September 2024.

Richard has more than 20 years of experience in the biopharmaceutical industry and global commercialization in a business-to-business environment. During his career he served in several increasingly senior commercial roles of which 10 years as Chief Commercial Officer at Synthon in the Netherlands and at Galenicum in Spain.

Richard graduated in Chemistry at the University of Amsterdam (cum laude) and holds a Ph.D in Biochemistry. The combination of his scientific background with his commercial and business mindset provides a unique combination for successful understanding of the end-to-end process of development, production and commercialization of medicines in the biopharmaceutical industry.

Noortje Hendriks
HR director

Noortje Hendriks

Noortje Hendriks is our HR Director since May 2023.

As HR Director, Noortje is responsible for shaping and implementing BioConnection’s people strategy. She supports the business by establishing clear organizational structures, well-defined roles and responsibilities, and effective HR processes that enable teams to work efficiently and collaboratively. At the same time, she focusses on connecting people, culture, and business objectives, creating an environment where employees feel supported, engaged, and able to grow. With a personal and approachable leadership style, Noortje contributes to BioConnection’s continued development as both a high-performing and people-centered organization.

Noortje has a background in HR and brings extensive HR experience from international and technical environments. Throughout her career, she has worked on both strategic HR initiatives and the human side of organizations, with a strong focus on talent development, collaboration, and building trust. 

“What I value most about BioConnection is the balance between professionalism and genuine personal attention. It is a growing organization where I enjoy building the future together with the people and the team — because when people are given the opportunity to grow, the organization ultimately grows with them.”

Iris Winter
Director QA/QP

Iris Winter

Iris Winter is our QA/QP Director and joined our organisation November 2025.

As Quality Director at BioConnection, she serves as the strategic force behind the organization's quality promise. She ensures that quality is not merely a static checklist but a dynamic component of business operations that fosters trust and drives growth. By designing long-term frameworks that anticipate shifting regulations and bridging the gap between Operations and Quality, she transforms complex challenges into collaborative successes.

With over 25 years of experience in the pharmaceutical and biotechnology sectors, she brings a wealth of expertise to her role as Quality Director. Her career is built on a strong professional foundation at industry leaders such as MSD Animal Health, Organon, and Intervet, complemented by experience at UMC St Radboud and as a specialist consultant for Winter Quality Partner.
Throughout her career, she has successfully navigated the complexities of global quality systems, GxP compliance, and large-scale manufacturing. From her technical roots in pharmaceutical research to her extensive experience as a Qualified Person (QP), she has a proven track record of aligning strict regulatory requirements with operational excellence.
She is a registered Pharmacist, having earned her degree from the University of Groningen.

“Joining BioConnection is a true challenge that pushes my expertise to the next level, requiring me to draw on every skill I’ve ever learned and more. I love helping the organization develop into one that is truly fit for the future, and I am a firm believer in collaborating company-wide to achieve our shared goals together.”

Alexandre Isabel
Business Development Manager

Alexandre Isabel

Maudy van den Berg
Business Development Manager

Maudy van den Berg

Frando van der Pas
Business Development Manager

Frando van der Pas

Matthieu Lacour
Business Development Manager

Matthieu Lacour

Let's connect

If you’re exploring fill & finish support for an upcoming or ongoing program, we’d love to learn more about your goals and how we can contribute to your success. Whether you’re evaluating partners for a new project or preparing for your next development milestone, our team is ready to support you with clarity, expertise, and flexibility.

Share a few details about your molecule, timelines, or specific challenges, and we’ll follow up with insights tailored to your needs. By understanding your priorities early, we can determine how our capabilities, capacity, and approach align with your plans. We’re here to help.